Tivic Health Systems, Inc. (TIVC): History, Ownership, Mission, How It Works & Makes Money

Ever wondered about the company pioneering non-invasive bioelectronic medicine? Tivic Health Systems, Inc. (TIVC), a health tech company, is focused on developing and commercializing bioelectronic and biologic medicines. But how did they get here, who's behind it, and what's their master plan? Keep reading to discover the history, ownership structure, mission, and business model that drive this innovative company forward.

Tivic Health Systems, Inc. (TIVC) History

Tivic Health Systems, Inc. Founding Timeline

Year established

Tivic Health Systems, Inc. was established in 2016.

Original location

The company is headquartered in Bridgewater, New Jersey.

Founding team members

The founding team includes Jennifer Ernst and Blake Gurfein.

Initial capital/funding

In 2018, Tivic Health Systems completed a Series A financing round, raising $9.2 million. This was followed by a Series B round in 2019, securing an additional $10 million. In September 2020, they closed $11.7 million in Series C funding.

Tivic Health Systems, Inc. Evolution Milestones

Tivic Health Systems, Inc. Transformative Moments

• FDA Clearance of ClearUP®: The FDA clearance of ClearUP® Sinus Relief marked a pivotal moment, validating the safety and efficacy of their bioelectronic device.
• Strategic Funding Rounds: Successful Series A, B, and C funding rounds provided crucial capital for product development, manufacturing, and market expansion.
• Retail Partnerships: Collaborations with major retailers significantly broadened the accessibility of ClearUP® to consumers nationwide.
• Focus on Bioelectronic Medicine: By focusing on bioelectronic medicine, Tivic Health carved out a unique position in the healthcare market, offering non-pharmaceutical solutions for common conditions.

To gain more insights into the company's guiding principles, visit Mission Statement, Vision, & Core Values of Tivic Health Systems, Inc. (TIVC).

Tivic Health Systems, Inc. (TIVC) Ownership Structure

Tivic Health Systems, Inc. features a mixed ownership structure that includes institutional investors, individual shareholders, and company insiders. The distribution of shares among these groups influences the company's governance and strategic direction.

Tivic Health Systems, Inc.'s Current Status

As of April 2025, Tivic Health Systems, Inc. is a public company, trading on the Nasdaq Stock Market under the ticker symbol TIVC. This status enables the company to raise capital through the issuance of stock and allows public investors to participate in the company's growth.

Tivic Health Systems, Inc.'s Ownership Breakdown

The ownership of TIVC is distributed among various types of shareholders, each holding a certain percentage of the company's outstanding shares. Understanding this breakdown is key to understanding the corporate governance and potential influences within the company.

Tivic Health Systems, Inc.'s Leadership

The leadership team is responsible for the day-to-day operations and strategic direction of Tivic Health Systems, Inc. Key members of the leadership team include:

• Jennifer Ernst: Chief Executive Officer
• Richard M. Fanelli: Chief Financial Officer

These individuals, along with other members of the executive team, guide the company’s strategy and execution. For more insights into the company's goals, explore the Mission Statement, Vision, & Core Values of Tivic Health Systems, Inc. (TIVC).

Tivic Health Systems, Inc. (TIVC) Mission and Values

Tivic Health Systems, Inc. is focused on restoring healthy function of the immune system through next-generation bioelectronics, taking a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia.

[Company's] Core Purpose

Official mission statement

Tivic Health is a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. The company takes a multi-pronged approach to treating the root causes of diseases caused by immune dysregulation and dysautonomia. The combination of bioelectronic and biologic medicines allows Tivic to target disorders and disease via both neural pathways and molecular approaches.

• Tivic Health is dedicated to developing and commercializing non-invasive bioelectronic medicine.
• The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions.
• Tivic Health aims to provide a natural alternative to traditional synthetic chemical methods used by the pharmaceutical industry.

Vision statement

Tivic Health's vision is to bring advances in bioelectronic medicine into first-line therapeutics, making it possible to regulate immune and autonomic system functions through electrical interventions.

• The company is building a robust pipeline that encompasses both bioelectronic and biologic mechanisms to deliver best-of-breed therapeutics.
• Tivic Health is focused on expanding its non-invasive vagus nerve stimulation (VNS) program, which has demonstrated a 400% increase in effects with personalized stimulation.
• The company aims to treat prevalent inflammatory and neurological diseases through VNS, targeting the body's vagus nerve, the command-and-control center of the body.

Company slogan/tagline

Restoring healthy function of the immune system through next-generation bioelectronics.

• Tivic Health is harnessing the power of bioelectronic medicine to change how chronic illnesses caused by inflammation are treated.
• The company is using its patent-pending platform to develop a pipeline of treatments aimed at providing safe and effective alternatives to traditional medical treatments that today can be invasive, inadequate, or both.

For insights into Tivic Health Systems, Inc.'s financial standing, you can explore this resource: Breaking Down Tivic Health Systems, Inc. (TIVC) Financial Health: Key Insights for Investors

Tivic Health Systems, Inc. (TIVC) How It Works

Tivic Health Systems, Inc. operates by developing and commercializing bioelectronic therapies that address inflammatory conditions. Their flagship product, ClearUP, is a non-pharmaceutical treatment for nasal congestion associated with allergies and sinus issues.

Tivic Health's Product/Service Portfolio

Tivic Health's Operational Framework

Tivic Health focuses on:

• Product Development and Manufacturing: Tivic Health develops and manufactures its bioelectronic devices, ensuring quality control and regulatory compliance.
• Sales and Marketing: The company employs a multi-channel sales strategy, including direct-to-consumer online sales, partnerships with retailers, and collaborations with healthcare providers.
• Clinical Research: Tivic Health invests in clinical studies to demonstrate the efficacy and safety of its products, supporting marketing claims and building credibility with healthcare professionals.
• Customer Support: They provide customer support to ensure proper usage and satisfaction, which is crucial for building customer loyalty and positive word-of-mouth.

Tivic Health's Strategic Advantages

Tivic Health's strategic advantages include:

• FDA Clearance: ClearUP has received FDA clearance, which validates its safety and efficacy, providing a competitive edge over non-cleared products.
• Patented Technology: The company holds patents on its bioelectronic technology, protecting its intellectual property and creating barriers to entry for competitors.
• Drug-Free Alternative: ClearUP offers a drug-free alternative for treating nasal congestion, appealing to consumers seeking non-pharmaceutical options.
• Direct-to-Consumer Model: Their direct-to-consumer sales model allows for higher margins and direct engagement with customers, facilitating feedback and product improvements.

To gain more insights into the investors and motivations behind Tivic Health, explore this profile: Exploring Tivic Health Systems, Inc. (TIVC) Investor Profile: Who’s Buying and Why?

Tivic Health Systems, Inc. (TIVC) How It Makes Money

Tivic Health Systems, Inc. primarily generates revenue through the sale of its flagship product, ClearUP, a non-invasive bioelectronic device designed to relieve sinus pain. Additional revenue is derived from accessories and related products that enhance the ClearUP experience.

Tivic Health Systems, Inc.'s Revenue Breakdown

Tivic Health Systems, Inc.'s Business Economics

• Pricing Strategy: The ClearUP device is priced to be competitive within the over-the-counter sinus relief market, balancing affordability with the perceived value of its drug-free, non-invasive technology.
• Cost of Goods Sold (COGS): A significant portion of the company's expenses is tied to the manufacturing and sourcing of the ClearUP device. Managing these costs is crucial for maintaining profitability.
• Marketing and Sales Expenses: A substantial investment is made in marketing and sales to drive consumer awareness and adoption of ClearUP. These expenses include digital marketing, retail partnerships, and direct-to-consumer advertising.
• R&D Investments: Continuous investment in research and development is essential for innovating and expanding the product line. This ensures the company remains competitive and addresses a broader range of consumer needs.

Tivic Health Systems, Inc.'s Financial Performance

• Gross Margin: Gross margin is a key indicator, reflecting the efficiency of production and pricing strategies. A healthy gross margin enables further investment in marketing and R&D. For instance, in the fiscal year 2024, the gross profit was $1.7 million, compared to $2.2 million in the prior year.
• Operating Expenses: These include sales and marketing, research and development, and general and administrative costs. Managing these expenses is vital for achieving profitability. For the year 2024, sales and marketing expenses decreased by $1.4 million, while general and administrative expenses decreased by $0.5 million compared to the previous year. Research and development costs also saw a decrease of $0.3 million.
• Net Loss: Tivic Health Systems, Inc. has experienced net losses as it invests in growth and market penetration. The capacity to reduce these losses over time is crucial for long-term sustainability. The net loss for 2024 was approximately $14.9 million, an improvement from the $18.9 million loss in the prior year, showcasing the impact of cost-cutting measures and strategic adjustments.
• Cash Flow: Monitoring cash flow is essential to ensure the company can fund its operations and strategic initiatives. Efficient management of working capital and access to financing are critical.

To gain more insights into Tivic Health Systems, Inc.'s financial performance, you might find this resource helpful: Breaking Down Tivic Health Systems, Inc. (TIVC) Financial Health: Key Insights for Investors

Tivic Health Systems, Inc. (TIVC) Market Position & Future Outlook

Tivic Health Systems is strategically positioned to capitalize on the growing neuromodulation market with its flagship product, ClearUP. While facing competition, the company aims to expand its market share through continued innovation and strategic partnerships.

Competitive Landscape

Opportunities & Challenges

Industry Position

Tivic Health operates within the neuromodulation market, a segment of the broader medical device industry. Key aspects of their industry positioning include:

• Innovative Technology: ClearUP represents a novel approach to treating sinus pain, differentiating Tivic Health from competitors offering traditional pharmaceutical or surgical solutions.
• Market Niche: The company focuses on the non-invasive treatment of sinus pain, catering to consumers seeking drug-free alternatives.
• Growth Potential: The neuromodulation market is expected to grow, driven by increasing demand for non-pharmacological pain management options.

For more in-depth insights into Tivic Health Systems, Inc., consider exploring this resource: Exploring Tivic Health Systems, Inc. (TIVC) Investor Profile: Who’s Buying and Why?